Long Corridor Asset Management LTD Bei Gene, Ltd. Transaction History
Long Corridor Asset Management LTD
- $85.5 Million
- Q3 2024
A detailed history of Long Corridor Asset Management LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 25,755 shares of BGNE stock, worth $5.63 Million. This represents 6.76% of its overall portfolio holdings.
Number of Shares
25,755
Previous 52,623
51.06%
Holding current value
$5.63 Million
Previous $7.51 Million
22.98%
% of portfolio
6.76%
Previous 9.32%
Shares
10 transactions
Others Institutions Holding BGNE
# of Institutions
253Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.31 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.41 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.13 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$1.09 Billion0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$810 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $22.7B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...